American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A Multiparameter molecular classifier to predict response to neoadjuvant lapatinib plus trastuzumab without chemotherapy in HER2+ breast cancer
    Journal Article

    Veeraraghavan, J.; Gutierrez, C.; De Angelis, C.; Davis, R.; Wang, T.; Pascual, T.; Selenica, P.; Sanchez, K.; Nitta, H.; Kapadia, M.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Results of an open-label, phase Ia/b study of pembrolizumab plus olaratumab in patients with unresectable, locally advanced, or metastatic soft-tissue sarcoma
    Journal Article

    Sch€offski, P.; Bahleda, R.; Wagner, A. J.; Burgess, M. A.; Junker, N.; Chisamore, M.; Peterson, P.; Szpurka, A. M.; Ceccarelli, M.; Tap, W. D.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • The GENIE BPC NSCLC cohort: A real-world repository integrating standardized clinical and genomic data for 1,846 patients with non-small cell lung cancer
    Journal Article

    Choudhury, N. J.; Lavery, J. A.; Brown, S.; de Bruijn, I.; Jee, J.; Tran, T. N.; Rizvi, H.; Arbour, K. C.; Whiting, K.; Shen, R.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Bavituximab decreases immunosuppressive myeloid-derived suppressor cells in newly diagnosed glioblastoma patients
    Journal Article

    Ina Ly, K.; Richardson, L. G.; Liu, M.; Muzikansky, A.; Cardona, J.; Lou, K.; Beers, A. L.; Chang, K.; Brown, J. M.; Ma, X.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Osimertinib and selpercatinib efficacy, safety, and resistance in a multicenter, prospectively treated cohort of EGFR-mutant and RET fusion-positive lung cancers
    Journal Article

    Rotow, J.; Patel, J. D.; Hanley, M. P.; Yu, H.; Awad, M.; Goldman, J. W.; Nechushtan, H.; Scheffler, M.; Kuo, C. H. S.; Rajappa, S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Apolipoprotein E2 stimulates protein synthesis and promotes melanoma progression and metastasis
    Journal Article

    Adaku, N.; Ostendorf, B. N.; Mei, W.; Tavazoie, S. F.
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer
    Journal Article

    Ricciuti, B.; Elkrief, A.; Alessi, J.; Wang, X.; Li, Y.; Gupta, H.; Muldoon, D. M.; Bertram, A. A.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Early changes in circulating cell-free KRAS G12C predict response to adagrasib in KRAS mutant non-small cell lung cancer patients
    Journal Article

    Paweletz, C. P.; Heavey, G. A.; Kuang, Y.; Durlacher, E.; Kheoh, T.; Chao, R. C.; Spira, A. I.; Leventakos, K.; Johnson, M. L.; Ou, S. H. I.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • An open-label phase I study of GDC-0927 in postmenopausal women with locally advanced or metastatic estrogen receptor–positive breast cancer
    Journal Article

    Chandarlapaty, S.; Dickler, M. N.; Perez Fidalgo, J. A.; Villanueva-Vázquez, R.; Giltnane, J.; Gates, M.; Chang, C. W.; Cheeti, S.; Fredrickson, J.; Wang, X.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • A multipronged unbiased strategy guides the development of an anti-EGFR/EPHA2-bispecific antibody for combination cancer therapy
    Journal Article

    El Zawily, A.; Vizeacoumar, F. S.; Dahiya, R.; Banerjee, S. L.; Bhanumathy, K. K.; Elhasasna, H.; Hanover, G.; Sharpe, J. C.; Sanchez, M. G.; Greidanus, P.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: